Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fp Spiromax Dose-ranging in Severe Persistent Asthma
NCT01576718Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Apr 2012
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 19
01
Overview
A Phase 2 trial of fluticasone propionate nasal spray in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Apr 2012; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01576718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576718.